Trial Profile
Phase II, Open, Randomized Comparative Trial of Two Different Schedules of Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting in Patients With Hematologic Malignancies Receiving Regimens Containing High-dose Cytarabine.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2012
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary) ; Ondansetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 15 Dec 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 15 Dec 2009 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 15 Dec 2009 Esai Inc Company added as trial sponsor as reported by ClinicalTrials.gov.